|
|
||||||||






* Department of Dermatology, Division of General Dermatology, Medical University of Vienna, and
Ludwig Boltzmann Institute for Angiogenesis, Microcirculation and Inflammation, Vienna, Austria; and
Department Dermatology, Palo Alto Medical Clinic, Palo Alto, CA 94301
Factors determining lymphatic differentiation in the adult organism are not yet well characterized. We have made the observation that mixed primary cultures of dermal blood endothelial cells (BEC) and lymphatic endothelial cells (LEC) grown under standard conditions change expression of markers during subculture: After passage 6, they uniformly express LEC-specific markers Prox-1 and podoplanin. Using sorted cells, we show that LEC but not BEC constitutively express IL-3, which regulates Prox-1 and podoplanin expression in LEC. The addition of IL-3 to the medium of BEC cultures induces Prox-1 and podoplanin. Blocking IL-3 activity in LEC cultures results in a loss of Prox-1 and podoplanin expression. In conclusion, endogenous IL-3 is required to maintain the LEC phenotype in culture, and the addition of IL-3 to BEC appears to induce transdifferentiation of BEC into LEC.
This article has been cited by other articles:
![]() |
M. J. Flister, A. Wilber, K. L. Hall, C. Iwata, K. Miyazono, R. E. Nisato, M. S. Pepper, D. C. Zawieja, and S. Ran Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-{kappa}B and Prox1 Blood, January 14, 2010; 115(2): 418 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bruyere and A. Noel Lymphangiogenesis: in vitro and in vivo models FASEB J, January 1, 2010; 24(1): 8 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Turner, R. S. Langley, K. L. Johnston, K. Gentil, L. Ford, B. Wu, M. Graham, F. Sharpley, B. Slatko, E. Pearlman, et al. Wolbachia Lipoprotein Stimulates Innate and Adaptive Immunity through Toll-like Receptors 2 and 6 to Induce Disease Manifestations of Filariasis J. Biol. Chem., August 14, 2009; 284(33): 22364 - 22378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Bixel and R. H. Adams Master and commander: continued expression of Prox1 prevents the dedifferentiation of lymphatic endothelial cells Genes & Dev., December 1, 2008; 22(23): 3232 - 3235. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Morris, A. S. Punjabi, and M. Lagunoff Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells J. Virol., September 1, 2008; 82(17): 8771 - 8779. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oka, C. Iwata, H. I. Suzuki, K. Kiyono, Y. Morishita, T. Watabe, A. Komuro, M. R. Kano, and K. Miyazono Inhibition of endogenous TGF-{beta} signaling enhances lymphangiogenesis Blood, May 1, 2008; 111(9): 4571 - 4579. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sivakumar, N. Sharma-Walia, H. Raghu, M. V. Veettil, S. Sadagopan, V. Bottero, L. Varga, R. Levine, and B. Chandran Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained Levels of Vascular Endothelial Growth Factors A and C Early during In Vitro Infection of Human Microvascular Dermal Endothelial Cells: Biological Implications J. Virol., February 15, 2008; 82(4): 1759 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
H J Van Kruiningen and J.-F. Colombel The forgotten role of lymphangitis in Crohn's disease Gut, January 1, 2008; 57(1): 1 - 4. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zeng, K. Opeskin, J. Goad, and E. D. Williams Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis Cancer Res., October 1, 2006; 66(19): 9566 - 9575. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kono, H. Kubo, C. Shimazu, Y. Ueda, M. Takahashi, K. Yanagi, N. Fujita, T. Tsuruo, H. Wada, and J. K. Yamashita Differentiation of Lymphatic Endothelial Cells From Embryonic Stem Cells on OP9 Stromal Cells Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2070 - 2076. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |